[1] |
Hartke J, Johnson M, Ghabril M. The diagnosis and treatment of hepatocellular carcinoma[J]. Semin Diagn Pathol, 2017, 34(2):153-159.
|
[2] |
Dhanasekaran R, Limaye A, Cabrera R. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics[J]. Hepat Med, 2012(4):19-37.
|
[3] |
Yan J, Fan Z, Wu X, et al. Circulating tumor cells are correlated with disease progression and treatment response in an orthotopic hepatocellular carcinoma model[J]. Cytometry A, 2015, 87(11):1020-1028.
|
[4] |
Fan ZC, Yan J, Liu GD, et al. Real-time monitoring of rare circulating hepatocellular carcinoma cells in an orthotopic model by in vivo flow cytometry assesses resection on metastasis[J]. Cancer Res, 2012, 72(10):2683-2691.
|
[5] |
Chen Q, Zhang XH, Massagué J. Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs[J]. Cancer Cell, 2011, 20(4):538-549.
|
[6] |
Li G, Chi CW, Shao XF, et al. Application of molecular imaging technology in evaluating the inhibiting effect of apigenin in vivo on subcutaneous hepatocellular carcinoma[J]. Biochem Biophys Res Commun, 2017, 487(1):122-127.
|
[7] |
de Almeida PE, van Rappard JR, Wu JC. In vivo bioluminescence for tracking cell fate and function[J]. Am J Physiol Heart Circ Physiol, 2011, 301(3):H663-671.
|
[8] |
Li Z, Hu X, Mao J, et al. Optimization of mesenchymal stem cells (MSCs) delivery dose and route in mice with acute liver injury by bioluminescence imaging[J]. Mol Imaging Biol, 2015, 17(2):185-194.
|
[9] |
Close DM, Xu T, Sayler GS, et al. In vivo bioluminescent imaging (BLI): noninvasive visualization and interrogation of biological processes in living animals[J]. Sensors, 2011, 11(1):180-206.
|
[10] |
Thalheimer A, Korb D, Bönicke L, et al. Noninvasive visualization of tumor growth in a human colorectal liver metastases xenograft model using bioluminescence in vivo imaging[J]. J Surg Res, 2013, 185(1):143-151.
|
[11] |
Weber J, Haberkorn U, Mier W. Cancer stratification by molecular imaging[J]. Int J Mol Sci, 2015, 16(3):4918-4946.
|
[12] |
Bannas P, Lenz A, Kunick V, et al. Molecular imaging of tumors with nanobodies and antibodies:timing and dosage are crucial factors for improved in vivo detection[J]. Contrast Media Mol Imaging, 2015, 10(5):367-378.
|
[13] |
Du L, Xu WT, Fan QM, et al. Tumorigenesis and spontaneous metastasis by luciferase-labeled human xenograft osteosarcoma cells in nude mice[J]. Chin Med J, 2012, 125(22):4022-4030.
|
[14] |
Zhou S, Zhao Z, Lin Y, et al. Suppression of pancreatic ductal adenocarcinoma growth by intratumoral delivery of attenuated Salmonella typhimurium using a dual fluorescent live tracking system[J]. Cancer Biol Ther, 2016, 17(7):732-740.
|
[15] |
Al Faraj A, Shaik AP, Shaik AS. Magnetic single-walled carbon nanotubes as efficient drug delivery nanocarriers in breast cancer murine model: noninvasive monitoring using diffusion-weighted magnetic resonance imaging as sensitive imaging biomarker[J]. Int J Nanomedicine, 2014(10):157-168.
|
[16] |
Jiang SN, Park SH, Lee HJ, et al. Engineering of bacteria for the visualization of targeted delivery of a cytolytic anticancer agent[J]. Mol Ther, 2013, 21(11):1985-1995.
|
[17] |
Leitão JM, Esteves da Silva JC. Firefly luciferase inhibition[J]. J Photochem Photobiol B, 2010, 101(1):1-8.
|
[18] |
Kim MH, Kim MH, Kim KS, et al. In vivo monitoring of CD44+ cancer stem-like cells by γ-irradiation in breast cancer[J]. Int J Oncol, 2016, 48(6):2277-2286.
|
[19] |
Everaert BR, Bergwerf I, De Vocht N, et al. Multimodal in vivo imaging reveals limited allograft survival, intrapulmonary cell trapping and minimal evidence for ischemia-directed BMSC homing[J]. BMC Biotechnol, 2012(12):93.
|